Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution...
Reexamination Certificate
2011-03-15
2011-03-15
Mi, Qiuwen (Department: 1655)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
C424S773000, C424S775000, C424S778000, C424S468000, C424S474000, C424S489000, C514S923000
Reexamination Certificate
active
07906154
ABSTRACT:
Supplemental compositions, and methods for administering same to a user, are provided for promoting a restful night's sleep by speedily inducing a person to fall asleep and to maintain sleep, as well as alleviating minor aches and pains so as to further improve the quality of a person sleep. The supplemental composition may include at least an extract of Valerian Root, an extract of Willow Bark and Melatonin or a derivative thereof. The supplemental composition may be provided for consumption at least one time daily, e.g., prior to sleep.
REFERENCES:
patent: 5641801 (1997-06-01), Wurtman
patent: 5681578 (1997-10-01), Sahley
patent: 5716978 (1998-02-01), Lewy
patent: 6080410 (2000-06-01), Bewicke
patent: 6277396 (2001-08-01), Dente
patent: 6312736 (2001-11-01), Kelly et al.
patent: 6383527 (2002-05-01), Artman et al.
patent: 6579543 (2003-06-01), McClung
patent: 6703412 (2004-03-01), Rosenthal
patent: 6770263 (2004-08-01), Brucker
patent: 6869622 (2005-03-01), Andrews et al.
patent: 7045158 (2006-05-01), Wolfson et al.
patent: 2001/0011083 (2001-08-01), Barr et al.
patent: 2002/0127285 (2002-09-01), Xiu
patent: 2003/0013639 (2003-01-01), Yurchak et al.
patent: 2003/0232091 (2003-12-01), Shefer et al.
patent: 2004/0063661 (2004-04-01), Linnane
patent: 2004/0247699 (2004-12-01), Delsing
patent: 2005/0129783 (2005-06-01), McClearly et al.
patent: 2005/0244517 (2005-11-01), Hall et al.
patent: 2005/0272690 (2005-12-01), Cremisi
patent: 62477 (1993-05-01), None
patent: 62477 (1993-05-01), None
patent: 2005/097101 (2005-10-01), None
Widy-tyszikiewicz et al, a randomized double blind study of sedative effects of phytotherapeutic containing valerian, hops, balm and motherworth versus placebo, Herba polonica, Tom XLIII 1997, No. 2, pp. 154-159.
Farmer et al: “Potential effects of herbal medicinals on perioperative care” Seminars in Anesthesia, Saunders, CO, New York, NY, US, vol. 20, No. 2, Jun. 1, 2001, pp. 110-117.
Supplementary European Search Report for EP 06 76 1118.
Horne, et al., “Aspirin and Human Sleep”, Electrenceph. and Clin. Neurophys., vol. 49 (1980) 409-13.
Murphy, et al., “Nonsteroidal Anti-Inflammatory Drugs Affect Normal Sleep Patterns in Humans”, Phys. and Behavior, vol. 55, No. 6 (1994) 1063-66.
Valenstein et al., “Benzodiazepine use among depressed patients treated in mental health settings”, Am J Psychiatry, vol. 161, No. 4 (2004) 654-61.
Ringdahl, et al., “Treatment of Primary Insomnia”, JABFP, vol. 17, No. 3 (2004) 212-19.
Benca et al., “Diagnosis and Treatment of Chronic Insomnia”, Psych. Serv., vol. 56, No. 3 (2005) 332-43.
Abourashed EA, Koetter U, Brattstrom A. In vitro binding experiments with a Valerian, hops and their fixed combination extract (Ze91019) to selected central nervous system receptors. Phytomedicine. Nov. 2004;11(7-8):633-8.).
Akhondzadeh et al, Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trial. J Neurol Neurosurg Psychiatry. Jul. 2003;74(7):863-6.
Akhondzadeh et al., Comparison of Lavandula angustifolia Mill. tincture and imipramine in the treatment of mild to moderate depression: a double-blind, randomized trial. Prog Neuropsychopharmacol Biol Psychiatry. Feb. 2003;27(1):123-7.
Akhondzadeh et al., Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam. J Clin Pharm Ther. Oct. 2001;26(5):363-7.
Andrade R. of membrane excitability in the central nervous system by serotonin receptor subtypes. Ann N Y Acad Sci. Dec. 15, 1998;861:190-203.
Aoshima et al., Effects of beer and hop on ionotropic gamma-aminobutyric acid receptors. J Agric Food Chem. Apr. 5, 2006;54(7):2514-9.).
Arangino et al., Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men. Am J Cardiol. May 1, 1999;83(9):1417-9.
Avery et al., Guidelines for prescribing melatonin. Ann Med. Feb. 1998;30(1):122-30.
Awad et al., Phytochemical and biological analysis of skullcap (Scutellaria lateriflora L.): a medicinal plant with anxiolytic properties. Phytomedicine. Nov. 2003;10(8):640-9.
Brzezinski et al., Effects of exogenous melatonin on sleep: a meta-analysis. Sleep Med Rev. Feb. 2005;9(1):41-50.
Buscemi et al., The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis. J Gen Intern Med. Dec. 2005;20(12):1151-8.
Chrubasik et al., Treatment of low back pain exacerbations with willow bark extract: a randomized double-blind study. Am J Med. Jul. 2000;109(1):9-14.
Dietz et al., Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro. Brain Res Mol Brain Res. Aug. 18, 2005;138(2):191-7.
Dietz et al., Xanthohumol isolated from Humulus lupulus Inhibits menadione-induced DNA damage through induction of quinone reductase. Chem Res Toxicol. Aug. 2005;18(8):1296-305.
Dijk et al., Integration of human sleep-wake regulation and circadian rhythmicity. J Appl Physiol. Feb. 2002;92(2):852-62.
Dimpfel et al,. Effects of lozenge containing lavender oil, extracts from hops, lemon balm and oat on electrical brain activity of volunteers. Eur J Med Res. Sep. 29, 2004;9(9):423-31.
Dubocovich et al., Functional MT1 and MT2 melatonin receptors in mammals. Endocrine. Jul. 2005:27(2)101-10.
Everson CA. Sustained sleep deprivation impairs host defense. Am J Physiol. Nov. 1993;265(5 Pt 2):R1148-54.
Feng et al.. Serotonin receptors modulate GABA(A) receptor channels through activation of anchored protein kinase C in prefrontal cortical neurons. J Neurosci. Sep. 1, 2001;21(17):6502-11.
Francis et al., Effect of valerian,Valeriana edulis, on sleep difficulties in children with intellectual deficits: randomised trial. Phytomedicine. May 2002;9(4):273-9.
Fussel et al., Effect of a fixed valerian-Hop extract combination (Ze 91019) on sleep polygraphy in patients with non-organic insomnia: a pilot study. Eur J Med Res. Sep. 18, 2000;5(9):385-90.
Gafner et al., Inhibition of [3H]-LSD binding to 5-HT7 receptors by flavonoids from Scutellaria lateriflora. J Nat Prod. Apr. 2003;66(4):535-7.
Gais et al., Early sleep triggers memory for early visual discrimination skills. Nat Neurosci. Dec. 2000;3(12):1335-9.
Gottlieb et al., Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med. Apr. 25, 2005;165(8):863-7.
Gyllenhaal et al., Efficacy and safety of herbal stimulants and sedatives in sleep disorders. Sleep Med Rev. Jun. 2000;4(3):229-251.
Hastings MH. Central clocking. Trends Neurosci. Oct. 1997;20(10):459-64.
Hohmann et al., Protective effects of the aerial parts ofSalvia officinalis, Melissa officinalisandLavandula angustifoliaand their constituents against enzyme-dependent and enzyme-independent lipid peroxidation. Planta Med. Aug. 1999;65(6):576-8.
Holmes et al., Lavender oil as a treatment for agitated behaviour in severe dementia: a placebo controlled study. Int J Geriatr Psychiatry. Apr. 2002;17(4):305-8.
Hughes et al., The role of melatonin and circadian phase in age-related sleep-maintenance insomnia: assessment in a clinical trial of melatonin replacement. Sleep. 1998;21(1):52-68.
Imagawa et al.,Coenzyme Q10, iron, and vitamin B6 in genetically-confirmed Alzheimer's disease. Lancet. Sep. 12, 1992;340(8820):671.
Irwin et al., Partial night sleep deprivation reduces natural killer and cellular immune responses in humans. FASEB J. Apr. 1996;10(5):643-53.
Kamikawa et al., Effects of coenzyme Q10 on exercise tolerance in chronic stable angina pectoris. Am J Cardiol. Aug. 1, 1985;56(4):247-51.
Kayumov et al., A randomized, double-blind, placebo-controlled crossover study of the effect of exogenous melatonin on delayed sleep phase syndrome. Psychosom Med. Jan.-Feb. 2001;63(1):40-8.
Kennedy et al. Modulation of mood and cognitive performance following acute administration ofMelissa officinalis(lemon balm). Pharmacol Biochem Behav. Jul. 2002;72(4):953-64.
Kennedy et al., Anxiolytic effects of a combination ofMelissa officinalisandVal
Chaudhuri Shan
Clement Kenneth
Heuer Marvin A.
LandOfFree
Compositions and methods for the induction and maintenance... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for the induction and maintenance..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for the induction and maintenance... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2672720